Tirofiban, eptifibatide, and abciximab in minimizing myocardial damage during high-risk coronary intervention: final results of the TEAM pilot trial

MLA

Samin K. Sharma, et al. “Tirofiban, Eptifibatide, and Abciximab in Minimizing Myocardial Damage during High-Risk Coronary Intervention: Final Results of the TEAM Pilot Trial.” Journal of the American College of Cardiology, vol. 39, Mar. 2002. EBSCOhost, https://doi.org/10.1016/s0735-1097(02)80315-1.

APA

Samin K. Sharma, Merwin Richard, Jonathan D. Marmur, Nohelia Perez, Annapooma S. Kini, Edward A. Fisher, & Javed Suleman. (2002). Tirofiban, eptifibatide, and abciximab in minimizing myocardial damage during high-risk coronary intervention: final results of the TEAM pilot trial. Journal of the American College of Cardiology, 39. https://doi.org/10.1016/s0735-1097(02)80315-1

Chicago

Samin K. Sharma, Merwin Richard, Jonathan D. Marmur, Nohelia Perez, Annapooma S. Kini, Edward A. Fisher, and Javed Suleman. 2002. “Tirofiban, Eptifibatide, and Abciximab in Minimizing Myocardial Damage during High-Risk Coronary Intervention: Final Results of the TEAM Pilot Trial.” Journal of the American College of Cardiology 39 (March). doi:10.1016/s0735-1097(02)80315-1.